A Phase III, Randomized Double Blind, Placebo-Controlled

A Phase III, Randomized Double Blind, Placebo-Controlled

Sponsor(s)

Osiris Therapeutics

Principal Investigator(s)Edmund K Waller, MD, PHD
Dates4/10/2007 - 4/30/2010